Comments

Corcept Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Corcept Therapeutics (CORT) operate in?

Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

CORTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$59.01

-0.84-1.40%

Pre-Market: 4:00 PM EDT

Q4 2024 Earnings were released on Wed Feb 26th, after the market close

The most recent conference call was at 17:00 PM, 2 days ago Click to view past webcast

Corcept Therapeutics (CORT) Forecast

News Earnings Corcept Therapeutics (CORT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Corcept Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CORT | Benzinga

Explore Corcept Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CORT.

Open	-
Close	-
Volume / Avg.	34.00 / 895.92K
Day Range	- - -
52 Wk Range	20.84 - 75.00
Market Cap	$6.23B
P/E Ratio	48.66
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	20.43%
Days to Cover	19.75

Recent News

Corcept Therapeutics' FDA-Approved Korlym Hits Main Goal In Cushing's Syndrome Patients With Difficult-To-Control Diabetes

Corcept Therapeutics reports positive Phase 4 CATALYST results, showing Korlym significantly improves hemoglobin A1c in hypercortisolism patients.

Vandana Singh

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast

Truist Securities raises the price target for Corcept Therapeutics to $76, driven by robust Korlym sales and promising relacorilant trials. The analyst highlights significant growth potential in the Cushing's syndrome market.

Vandana Singh

Corcept Moves 6.5% Higher: Will This Strength Last?

Corcept Therapeutics (NASDAQ: CORT) shares soared 6.5% in the last trading session to close at $42.27. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 15.7% gain over the past four weeks.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	34.00 / 895.92K
Day Range	- - -
52 Wk Range	20.84 - 75.00
Market Cap	$6.23B
P/E Ratio	48.66
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	20.43%
Days to Cover	19.75

About Corcept Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and d...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Corcept Therapeutics (CORT) stock?

You can purchase shares of Corcept Therapeutics (NASDAQ:CORT) through any online brokerage.

View our list of the best stock brokerages

Who are Corcept Therapeutics (CORT) competitors?

Other companies in Corcept Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Corcept Therapeutics (CORT) stock?

Corcept Therapeutics has a consensus price target of $67.86.

What is the current price for Corcept Therapeutics (CORT)?

The stock price for Corcept Therapeutics (NASDAQ: CORT) is $59.01 last updated February 27, 2025 at 4:00 PM EST.

Does Corcept Therapeutics (CORT) pay a dividend?

There are no upcoming dividends for Corcept Therapeutics.

When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?

Corcept Therapeutics’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is Corcept Therapeutics (CORT) going to split?

There is no upcoming split for Corcept Therapeutics.

What sector and industry does Corcept Therapeutics (CORT) operate in?

Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Corcept Therapeutics Stock Price, Quotes and Forecasts

Corcept Therapeutics (CORT) Forecast

Edge Rankings

Stock Score Locked: Edge Members Only

Bulls vs Bears

Corcept Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CORT | Benzinga

Recent News

Financials

Analyst Trends and Forecast

Analyst Rating and Forecast

Compare

FAQ

How do I buy Corcept Therapeutics (CORT) stock?

Who are Corcept Therapeutics (CORT) competitors?

What is the forecast, or price target, for Corcept Therapeutics (CORT) stock?

What is the current price for Corcept Therapeutics (CORT)?

Does Corcept Therapeutics (CORT) pay a dividend?

When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?

Is Corcept Therapeutics (CORT) going to split?

What sector and industry does Corcept Therapeutics (CORT) operate in?

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga